• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Guardant Health, Inc. - Common Stock (NQ:GH)

    91.43 -1.59 (-1.71%)
    Streaming Delayed Price Updated: 1:29 PM EST, Mar 5, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 675,139
    Open 92.30
    Bid (Size) 91.10 (200)
    Ask (Size) 91.45 (200)
    Prev. Close 93.02
    Today's Range 91.10 - 96.52
    52wk Range 34.88 - 120.74
    Shares Outstanding 101,298,669
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Guardant Health Launches Coast-to-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to Over 100 Communities Across America
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Actor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Screening and Shield Blood Test, Sharing His Experience Getting Screened
    From Guardant Health, Inc.
    Via Business Wire

    Performance

    YTD
    -10.1%
    -10.1%
    1 Month
    -20.4%
    -20.4%
    3 Month
    -13.7%
    -13.7%
    6 Month
    +40.5%
    +40.5%
    1 Year
    +120.4%
    +120.4%

    More News

    Read More
    News headline image
    Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know
    Via StockStory
    Topics Economy Stocks
    Guardant Health Inc (NASDAQ:GH) Posts Strong Q4 Revenue Beat and Bullish 2026 Outlook ↗
    Via Chartmill
    News headline image
    Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    The Great Rotation: Small-Caps Break Record Highs as the 'Catch-Up' Trade Ignites
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    News headline image
    Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know
    Via StockStory
    Topics Economy Government World Trade
    News headline image
    Guardant Health (NASDAQ:GH) Surprises With Q4 CY2025 Sales
    Via StockStory
    News headline image
    Guardant Health Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Earnings To Watch: Guardant Health (GH) Reports Q4 Results Tomorrow
    Via StockStory
    Topics Artificial Intelligence Economy World Trade
    News headline image
    3 Unprofitable Stocks Walking a Fine Line
    Via StockStory
    News headline image
    Small Caps Roar: Russell 2000 Surges as Cooling Inflation Ignites Rate Cut Hopes
    Via MarketMinute
    Topics Bonds ETFs Economy
    News headline image
    Guardant Health to Participate in Upcoming Investor Conferences
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Largest Published Study of Molecular Residual Disease (MRD) in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence After Surgery to Support Timely Treatment Decisions
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    3 Unpopular Stocks We Think Twice About
    Via StockStory
    News headline image
    Should You Buy Guardant Health Before Feb. 19? ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Guardant Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Guardant Health Receives FDA Approval for Guardant360® CDx as Companion Diagnostic for BRAFTOVI® (encorafenib) Combination in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Guardant Health (NASDAQ:GH): Strongest Q3 Results from the Testing & Diagnostics Services Group
    Via StockStory
    News headline image
    CS Diagnostics (OTCQB: CSDX) Advances Infection Control and Oncology Innovation Plus – IVP, SAFX, JTAI, OCG, BMXI Inside
    Via AB Newswire
    Topics Intellectual Property
    News headline image
    GRAIL Surges as Canaccord Genuity Sets Ambitious $105 Price Target Following Robust 2025 Growth
    Via MarketMinute
    News headline image
    Adaptive Biotechnologies Surges as Preliminary 2025 Results Signal a Turning Point in MRD Commercialization
    Via MarketMinute
    News headline image
    Biodesix Shares Rocket 42% on Record FY2025 Results and Path to Profitability
    Via MarketMinute
    Topics Artificial Intelligence Death
    News headline image
    Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results
    From Guardant Health, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Guardant Health, Inc. - Common Stock publicly traded?
    Yes, Guardant Health, Inc. - Common Stock is publicly traded.
    What exchange does Guardant Health, Inc. - Common Stock trade on?
    Guardant Health, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Guardant Health, Inc. - Common Stock?
    The ticker symbol for Guardant Health, Inc. - Common Stock is GH on the Nasdaq Stock Market
    What is the current price of Guardant Health, Inc. - Common Stock?
    The current price of Guardant Health, Inc. - Common Stock is 91.43
    When was Guardant Health, Inc. - Common Stock last traded?
    The last trade of Guardant Health, Inc. - Common Stock was at 03/05/26 01:29 PM ET
    What is the market capitalization of Guardant Health, Inc. - Common Stock?
    The market capitalization of Guardant Health, Inc. - Common Stock is 9.26B
    How many shares of Guardant Health, Inc. - Common Stock are outstanding?
    Guardant Health, Inc. - Common Stock has 9B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.